Zhiqiang Guo
Shenyang, 110870, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Temperature-dependent flexible hybrid capacitors based on Ni(OH)2@NiS electrode materials.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: August 19, 2025
Structural and anti-ovarian cancer insights into the immunoglobulin G-glabridin nanocomplex.
Journal: International journal of biological macromolecules
Published: November 04, 2024
Overview of splicing variation in ovarian cancer.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: October 14, 2024
Structure-based virtual screening discovers novel PKMYT1 inhibitors.
Journal: RSC medicinal chemistry
Published: May 26, 2024
Unruptured ovarian ectopic pregnancy: Two case reports and literature review.
Journal: Frontiers in physiology
Published: September 04, 2022
Postmenopausal giant ovarian tumor: a rare case report and literature review.
Journal: Menopause (New York, N.Y.)
Published: July 26, 2022
Construction and Characterization of Cadherin 6 (CDH6)-Targeting Chimeric Antigen Receptor (CAR) Modified T Cells.
Journal: Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer
Published: April 04, 2022
Differences in Characteristics and Outcomes Between Large-Cell Neuroendocrine Carcinoma of the Ovary and High-Grade Serous Ovarian Cancer: A Retrospective Observational Cohort Study.
Journal: Frontiers in oncology
Published: March 09, 2022
Uterine Tumor Resembling Ovarian Sex Cord Tumors (UTROSCT): Two Case Reports of the Rare Uterine Neoplasm with Literature Review.
Journal: Current medical imaging
Published: September 24, 2021
Primary neuroendocrine tumors of the ovary: Management and outcomes.
Journal: Cancer medicine
Published: August 09, 2021
Correction: PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer.
Journal: PloS one
Published: October 19, 2017
Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models.
Journal: Oncotarget
Published: June 23, 2017
Last Updated: 09/26/2026